A device that provides tactile braille and graphics for blind users
Microfluidic technology for a full-page braille and graphical tactile display
This study is creating a new tablet-like device with a special touch screen that can show braille and pictures for blind people, making it easier for them to learn and access information in a fun and interactive way.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Newhaptics Corp. NIH-funded |
| Lab location | 1 site (Ann Arbor, UNITED STATES) |
| Project ID | NIH-10590755 on NIH RePORTER |
What this research studies
This research aims to develop an innovative tablet-like device that features a multiline refreshable braille and tactile graphics display specifically designed for blind individuals. Utilizing advanced microfluidic technology, the device will allow thousands of tiny tactile pins to be raised and lowered interactively, enabling users to engage with braille and tactile graphics in a dynamic way. This technology will enhance educational opportunities by providing access to information that is currently limited to hardcopy formats, thereby promoting independence and success for blind students. The device is designed to be low-cost and highly manufacturable, making it accessible to a wider audience.
Who could benefit from this research
Good fit: Ideal candidates for this research are blind or visually impaired individuals, particularly students and professionals who rely on braille and tactile graphics for education and work.
Not a fit: Patients who are not blind or visually impaired will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve educational access and quality of life for blind individuals by providing them with a versatile tool for reading and interacting with information.
How similar studies have performed: Similar research has shown promise in developing tactile devices for blind users, indicating a potential for success with this innovative approach.
Where this research is happening
Ann Arbor, UNITED STATES
- Newhaptics Corp. — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Russomanno, Alexander — Newhaptics Corp.
- Study coordinator: Russomanno, Alexander
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.